Supporting HIV care through education and innovation

AETC ShareSpot: Drug Interactions with Dolutegravir

AETC ShareSpot: Drug Interactions with Dolutegravir

Monday, December 2, 2013

TARGET Center

Description

Learn about Dolutegravir, a newly approved integrase inhibitor, and its drug interactions with other medications and nutritional products in the November 12, 2013 issue of AETC Sharespot, which provides links to additional information on integrase inihibitor intereactions available on HIVInsite.

See also the AIDSInfo site for technical information on Dolutegravir and other HIV/AIDS medications.   

Add a Comment

Log in or register to post comments